[ {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RA-kOJcRDmtZDXRiS3BF1zxai20gt7aPt7n2MeMnNwjMA",
    "@type" : [ "http://www.nanopub.org/nschema#Nanopublication" ],
    "http://www.nanopub.org/nschema#hasAssertion" : [ {
      "@id" : "http://purl.org/np/RA-kOJcRDmtZDXRiS3BF1zxai20gt7aPt7n2MeMnNwjMA#assertion"
    } ],
    "http://www.nanopub.org/nschema#hasProvenance" : [ {
      "@id" : "http://purl.org/np/RA-kOJcRDmtZDXRiS3BF1zxai20gt7aPt7n2MeMnNwjMA#provenance"
    } ],
    "http://www.nanopub.org/nschema#hasPublicationInfo" : [ {
      "@id" : "http://purl.org/np/RA-kOJcRDmtZDXRiS3BF1zxai20gt7aPt7n2MeMnNwjMA#pubInfo"
    } ]
  } ],
  "@id" : "http://purl.org/np/RA-kOJcRDmtZDXRiS3BF1zxai20gt7aPt7n2MeMnNwjMA#Head"
}, {
  "@graph" : [ {
    "@id" : "http://identifiers.org/drugbank/DB01267",
    "@type" : [ "https://w3id.org/biolink/vocab/Drug" ],
    "http://www.w3.org/2000/01/rdf-schema#label" : [ {
      "@value" : "Paliperidone"
    } ],
    "https://w3id.org/biolink/vocab/category" : [ {
      "@id" : "https://w3id.org/biolink/vocab/Drug"
    } ]
  }, {
    "@id" : "http://purl.obolibrary.org/obo/MONDO_0001156",
    "@type" : [ "https://w3id.org/biolink/vocab/Disease" ],
    "http://www.w3.org/2000/01/rdf-schema#label" : [ {
      "@value" : "Borderline personality disorder"
    } ],
    "https://w3id.org/biolink/vocab/category" : [ {
      "@id" : "https://w3id.org/biolink/vocab/Disease"
    } ]
  }, {
    "@id" : "http://purl.org/np/RA-kOJcRDmtZDXRiS3BF1zxai20gt7aPt7n2MeMnNwjMA#association",
    "@type" : [ "https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation" ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#object" : [ {
      "@id" : "http://purl.obolibrary.org/obo/MONDO_0001156"
    } ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate" : [ {
      "@id" : "https://w3id.org/biolink/vocab/treats"
    } ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#subject" : [ {
      "@id" : "http://identifiers.org/drugbank/DB01267"
    } ],
    "http://www.w3.org/2000/01/rdf-schema#label" : [ {
      "@value" : "Similarly, De Cos Milas et al. [6] described their clinical experience with paliperidone in adolescents. They presented 3 males and 2 females, age between 15 and 17 years. Diagnoses were autism, borderline personality dis- order, schizotypal personality disorder, personality disorder not otherwise specified, and schizophrenia. Prescribed dose was 3–9 mg/day, and actual mean time of treatment duration is 5.8 months. In 4 cases, paliperidone was initiated as a change from other antipsychotic. There were no adverse effects that required discontinuation and in all cases symptoms improved."
    } ],
    "https://w3id.org/biolink/vocab/aggregator_knowledge_source" : [ {
      "@id" : "https://w3id.org/biolink/infores/knowledge-collaboratory"
    } ],
    "https://w3id.org/biolink/vocab/category" : [ {
      "@id" : "https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation"
    } ],
    "https://w3id.org/biolink/vocab/has_population_context" : [ {
      "@id" : "http://purl.org/np/RA-kOJcRDmtZDXRiS3BF1zxai20gt7aPt7n2MeMnNwjMA#context"
    } ],
    "https://w3id.org/biolink/vocab/publications" : [ {
      "@id" : "http://www.ncbi.nlm.nih.gov/pubmed/31096228"
    } ],
    "https://w3id.org/biolink/vocab/relation" : [ {
      "@id" : "http://purl.obolibrary.org/obo/NCIT_C94303"
    } ]
  }, {
    "@id" : "http://purl.org/np/RA-kOJcRDmtZDXRiS3BF1zxai20gt7aPt7n2MeMnNwjMA#context",
    "@type" : [ "https://w3id.org/biolink/vocab/Cohort" ],
    "http://www.w3.org/2000/01/rdf-schema#label" : [ {
      "@value" : "Adolescents (15-17)"
    } ],
    "https://w3id.org/biolink/vocab/category" : [ {
      "@id" : "https://w3id.org/biolink/vocab/Cohort"
    } ]
  } ],
  "@id" : "http://purl.org/np/RA-kOJcRDmtZDXRiS3BF1zxai20gt7aPt7n2MeMnNwjMA#assertion"
}, {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RA-kOJcRDmtZDXRiS3BF1zxai20gt7aPt7n2MeMnNwjMA#assertion",
    "http://www.w3.org/ns/prov#wasAttributedTo" : [ {
      "@id" : "https://orcid.org/0000-0002-7641-6446"
    } ]
  } ],
  "@id" : "http://purl.org/np/RA-kOJcRDmtZDXRiS3BF1zxai20gt7aPt7n2MeMnNwjMA#provenance"
}, {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RA-kOJcRDmtZDXRiS3BF1zxai20gt7aPt7n2MeMnNwjMA",
    "http://www.w3.org/ns/prov#generatedAtTime" : [ {
      "@type" : "http://www.w3.org/2001/XMLSchema#dateTime",
      "@value" : "2022-09-16T11:50:50.806905"
    } ],
    "http://www.w3.org/ns/prov#wasAttributedTo" : [ {
      "@id" : "https://orcid.org/0000-0002-1501-1082"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate" : [ {
      "@id" : "http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY"
    } ]
  }, {
    "@id" : "http://purl.org/np/RA-kOJcRDmtZDXRiS3BF1zxai20gt7aPt7n2MeMnNwjMA#sig",
    "http://purl.org/nanopub/x/hasAlgorithm" : [ {
      "@value" : "RSA"
    } ],
    "http://purl.org/nanopub/x/hasPublicKey" : [ {
      "@value" : "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCR9fz0fKCdWOWC+pxhkQhEM/ppbdIYe5TLSdj+lJzSlv9mYBaPgrzVezSwwbmhlHBPDZa4/vHycU315BdmUGq+pXllp9+rWFfrb+kBJwhZjpG6BeyyXBsRFz4jmQVxl/ZYHilQTh/XalYzKkEAyTiEMPee4Kz61PaWOKH24CsnOQIDAQAB"
    } ],
    "http://purl.org/nanopub/x/hasSignature" : [ {
      "@value" : "fewIHVCgiJ6DpfYFfOYh29vch+b6cqjGXKyMJCp/fcduijCwaBxmTGzNbQ29JfjdqEyOrBVdPX8cEY3pmGP+ZOaz+WkhC3BPIwtsLVsSFHg15vXxoQDyVforEmQNBjseD4adD8adDCs52WdILC+gdqYtdy6cdj//+pqQ2wDtxlE="
    } ],
    "http://purl.org/nanopub/x/hasSignatureTarget" : [ {
      "@id" : "http://purl.org/np/RA-kOJcRDmtZDXRiS3BF1zxai20gt7aPt7n2MeMnNwjMA"
    } ]
  }, {
    "@id" : "https://w3id.org/biolink/vocab/",
    "http://purl.org/pav/version" : [ {
      "@value" : "2.3.0"
    } ]
  } ],
  "@id" : "http://purl.org/np/RA-kOJcRDmtZDXRiS3BF1zxai20gt7aPt7n2MeMnNwjMA#pubInfo"
} ]